| Literature DB >> 33347610 |
Tatum S Simonson1, Tracy L Baker2, Robert B Banzett3, Tammie Bishop4, Jerome A Dempsey5, Jack L Feldman6, Patrice G Guyenet7, Emma J Hodson8,9, Gordon S Mitchell10, Esteban A Moya1, Brandon T Nokes1, Jeremy E Orr1, Robert L Owens1, Marc Poulin11, Jean M Rawling12, Christopher N Schmickl1, Jyoti J Watters2, Magdy Younes13, Atul Malhotra1.
Abstract
The clinical presentation of COVID-19 due to infection with SARS-CoV-2 is highly variable with the majority of patients having mild symptoms while others develop severe respiratory failure. The reason for this variability is unclear but is in critical need of investigation. Some COVID-19 patients have been labelled with 'happy hypoxia', in which patient complaints of dyspnoea and observable signs of respiratory distress are reported to be absent. Based on ongoing debate, we highlight key respiratory and neurological components that could underlie variation in the presentation of silent hypoxaemia and define priorities for subsequent investigation.Entities:
Keywords: COVID-19; SARS-CoV-2; dyspnoea; happy hypoxia; silent hypoxaemia
Mesh:
Year: 2021 PMID: 33347610 PMCID: PMC7902403 DOI: 10.1113/JP280769
Source DB: PubMed Journal: J Physiol ISSN: 0022-3751 Impact factor: 6.228